Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.570
-0.040 (-1.53%)
Nov 4, 2024, 4:00 PM EST - Market closed
Nautilus Biotechnology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 4.41 | 19.4 | 114.52 | 185.62 | 36.61 | 0.6 |
Short-Term Investments | 136.2 | 154.02 | 69.95 | 160.11 | 40.14 | 16.06 |
Cash & Short-Term Investments | 140.61 | 173.42 | 184.47 | 345.73 | 76.74 | 16.66 |
Cash Growth | -23.29% | -5.99% | -46.64% | 350.51% | 360.66% | - |
Prepaid Expenses | 3.6 | 3.42 | 2.74 | 3.49 | 0.92 | 0.31 |
Total Current Assets | 144.21 | 176.84 | 187.21 | 349.22 | 77.66 | 16.96 |
Property, Plant & Equipment | 33.7 | 36.9 | 32.57 | 31.86 | 6.21 | 1.12 |
Long-Term Investments | 80.62 | 90.65 | 129.17 | 16.37 | - | - |
Long-Term Deferred Charges | - | - | - | - | 0.21 | - |
Other Long-Term Assets | 1.18 | 1.18 | 1.11 | 1 | 0.93 | 0.46 |
Total Assets | 259.7 | 305.57 | 350.05 | 398.45 | 85.01 | 18.54 |
Accounts Payable | 1.49 | 1.64 | 1.27 | 1.72 | 0.47 | 0.29 |
Accrued Expenses | 2.9 | 3.57 | 3.09 | 2.73 | 0.94 | 0.12 |
Current Portion of Leases | 3.96 | 3.54 | 1.99 | 0.97 | 1.48 | - |
Other Current Liabilities | 0.31 | 0.38 | 0.44 | 0.39 | 0.13 | 0.08 |
Total Current Liabilities | 8.66 | 9.12 | 6.79 | 5.81 | 3.02 | 0.49 |
Long-Term Leases | 27.61 | 31.09 | 28.34 | 29.06 | 3.3 | - |
Total Liabilities | 36.27 | 40.21 | 35.13 | 34.87 | 6.31 | 0.49 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0 |
Additional Paid-In Capital | 478.12 | 467.83 | 455.33 | 444.39 | 0.6 | 0.19 |
Retained Earnings | -255.43 | -202.24 | -138.56 | -80.64 | -30.33 | -14.71 |
Comprehensive Income & Other | 0.73 | -0.26 | -1.85 | -0.18 | 0 | 0.01 |
Total Common Equity | 223.43 | 265.35 | 314.92 | 363.58 | -29.72 | -14.51 |
Shareholders' Equity | 223.43 | 265.35 | 314.92 | 363.58 | 78.7 | 18.05 |
Total Liabilities & Equity | 259.7 | 305.57 | 350.05 | 398.45 | 85.01 | 18.54 |
Total Debt | 31.57 | 34.63 | 30.33 | 30.03 | 4.78 | - |
Net Cash (Debt) | 109.04 | 138.79 | 154.14 | 315.7 | 71.97 | 16.66 |
Net Cash Growth | -26.15% | -9.96% | -51.17% | 338.67% | 332.00% | - |
Net Cash Per Share | 0.87 | 1.11 | 1.24 | 3.74 | 2.47 | 2.75 |
Filing Date Shares Outstanding | 125.56 | 125.1 | 124.87 | 124.43 | 9.11 | 6.07 |
Total Common Shares Outstanding | 125.56 | 125.07 | 124.87 | 124.3 | 9.11 | 6.07 |
Working Capital | 135.54 | 167.72 | 180.42 | 343.41 | 74.64 | 16.47 |
Book Value Per Share | 1.78 | 2.12 | 2.52 | 2.92 | -3.26 | -2.39 |
Tangible Book Value | 223.43 | 265.35 | 314.92 | 363.58 | -29.72 | -14.51 |
Tangible Book Value Per Share | 1.78 | 2.12 | 2.52 | 2.92 | -3.26 | -2.39 |
Machinery | 8.83 | 7.88 | 5.42 | 4.19 | 2.49 | 1.64 |
Construction In Progress | 1.49 | 0.9 | 1.24 | 0.28 | - | - |
Leasehold Improvements | 0.12 | 0.12 | 0.01 | 0.01 | 0.17 | 0.23 |
Source: S&P Capital IQ. Standard template. Financial Sources.